Über uns
Dr Mohamad Abdel-Hadi is a distinguished Consultant in Gynecologic Oncology with extensive experience in the field of women's health and cancer care. He is recognised for his leadership in establishing specialised oncology services within tertiary care settings in the region. His professional focus lies in the comprehensive management of gynaecological malignancies, where he combines clinical expertise with a dedication to patient-centred care. Dr Abdel-Hadi is also deeply involved in medical education, having served as a programme director for fellowship training, ensuring the next generation of specialists adheres to high standards of practice.
In his clinical practice, Dr Abdel-Hadi specialises in the diagnosis, surgical treatment, and long-term management of cancers affecting the female reproductive system, including ovarian, uterine, and cervical malignancies. He employs a multidisciplinary approach to complex cases, working closely to tailor treatment plans that address both the medical and emotional needs of his patients. His expertise extends to advanced surgical techniques required for intricate pelvic procedures, aiming to achieve the best possible oncological outcomes while preserving quality of life.
Dr Abdel-Hadi completed his medical training with an MBBS from the University of Jordan, followed by a residency in Obstetrics and Gynaecology at Jordan University Hospital. He further advanced his sub-specialisation by completing a Fellowship in Gynecologic Oncology at the Sydney Cancer Center and Royal Prince Alfred Hospital in Australia. He holds board certification in Obstetrics and Gynaecology and maintains an active interest in clinical research, particularly regarding risk factors for ovarian cancer in the region.
In his clinical practice, Dr Abdel-Hadi specialises in the diagnosis, surgical treatment, and long-term management of cancers affecting the female reproductive system, including ovarian, uterine, and cervical malignancies. He employs a multidisciplinary approach to complex cases, working closely to tailor treatment plans that address both the medical and emotional needs of his patients. His expertise extends to advanced surgical techniques required for intricate pelvic procedures, aiming to achieve the best possible oncological outcomes while preserving quality of life.
Dr Abdel-Hadi completed his medical training with an MBBS from the University of Jordan, followed by a residency in Obstetrics and Gynaecology at Jordan University Hospital. He further advanced his sub-specialisation by completing a Fellowship in Gynecologic Oncology at the Sydney Cancer Center and Royal Prince Alfred Hospital in Australia. He holds board certification in Obstetrics and Gynaecology and maintains an active interest in clinical research, particularly regarding risk factors for ovarian cancer in the region.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mohamad Abdel-Hadi
Ausbildung & Training
-
2011–2017 MD · Medicine and Surgery
-
2017–2021 Residency · Onkologie
Karriere & Anstellungen
-
2021-09–2022-08 Junior consultant
Lizenzen & Versicherung
Medizinische Lizenzen
SA — Organización Médica Colegial de España (OMC)
Facharztzertifikate
European Board of Onkologie
Berufshaftpflichtversicherung:
AmTrust Europe · 3,000,000 EUR Deckung · No claims on file
Durchgeführte Verfahren
| Verfahren | Code | Lebenszeit-Anzahl |
|---|---|---|
| GP consultation | 99213 | 573 |
| Annual physical exam | 99395 | 723 |
| Vaccination administration | 90471 | 2,867 |
| Minor procedure (skin) | 17110 | 1,668 |
Leistungen & Preise
| Leistung | Dauer | Modalität | Preis |
|---|---|---|---|
| New patient consultation (60m) | 60 Min. | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 Min. | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 Min. | in_clinic | 270.00 EUR |
| Minor procedure (skin) | 90 Min. | in_clinic | 360.00 EUR |
Praxis, Team & in der Praxis
Videos
Forschung & Publikationen
h-Index: 21 · i10: 11
-
Long-term follow-up of Onkologie across SA
DOI: 10.6175/euroclin.2026.0 · PMID: 33600566 · zitiert von 141
-
Validation of clinical scoring in Onkologie
DOI: 10.5933/euroclin.2025.1 · PMID: 33929234 · zitiert von 39
-
Long-term follow-up of Onkologie across SA
DOI: 10.6962/euroclin.2024.2 · PMID: 35975720 · zitiert von 9
-
Validation of clinical scoring in Onkologie
DOI: 10.5524/euroclin.2023.3 · PMID: 39102562 · zitiert von 99
Eingeladene Vorträge
- Practical updates in Onkologie European Annual Congress (Onkologie) · Vienna · 2024 · invited
- Single-centre experience in Onkologie National Society Meeting · Dammam · 2023 · oral abstract
Auszeichnungen & Mitgliedschaften
Auszeichnungen
- 🏆 Top-rated Onkologie — Dammam · EuroClinics Patient Choice · 2025 · regional
Gesellschaftsmitgliedschaften
- WONCA Europe — Family Doctors — Member · Seit 2022
- national college of family doctors — Member · Seit 2022
- European Union of Medical Specialists (UEMS) — Member · Seit 2022
Artikel dieses Arztes
- Patient education Patient guide to Onkologie
- Awareness When should you see a onkologie?
Für internationale Patienten
- Koordinator
- Patient liaison · mohamad.abdel.hadi@euroclinics.example
Standort
1 TagPatientenbewertungen
Teilen Sie Ihre Erfahrung — Helfen Sie anderen Patienten, den richtigen Arzt zu finden. Bewertung schreiben →
Aktuelle Bewertungen
-
★★★★★ ✓ Verifiziert Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verifiziert Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verifiziert Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.